GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oruka Therapeutics Inc (FRA:HQ1) » Definitions » Price-to-Tangible-Book

Oruka Therapeutics (FRA:HQ1) Price-to-Tangible-Book : 2.31 (As of Dec. 14, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Oruka Therapeutics Price-to-Tangible-Book?

As of today (2024-12-14), Oruka Therapeutics's share price is €20.20. Oruka Therapeutics's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was €8.74. Hence, Oruka Therapeutics's Price to Tangible Book Ratio of today is 2.31.

The historical rank and industry rank for Oruka Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

FRA:HQ1's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.81
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Oruka Therapeutics's share price is €20.20. Oruka Therapeutics's Book Value per Sharefor the quarter that ended in Sep. 2024 was €8.74. Hence, Oruka Therapeutics's P/B Ratio of today is 2.31.


Oruka Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Oruka Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oruka Therapeutics Price-to-Tangible-Book Chart

Oruka Therapeutics Annual Data
Trend
Price-to-Tangible-Book

Oruka Therapeutics Quarterly Data
Mar24 Jun24 Sep24
Price-to-Tangible-Book - - 2.30

Competitive Comparison of Oruka Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Oruka Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oruka Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oruka Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Oruka Therapeutics's Price-to-Tangible-Book falls into.



Oruka Therapeutics Price-to-Tangible-Book Calculation

Oruka Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=20.20/8.738
=2.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Oruka Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Oruka Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Oruka Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
Address
221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Website
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Oruka Therapeutics Headlines

No Headlines